LOS ANGELES, CA and PERTH, WESTERN AUSTRALIA--(Marketwire - Jul 17, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) (MMR) and VisiInc PLC have announced a combined product offering representing an immediate solution within Australia for the Personally Controlled eHealth Record (PCEHR) standard as defined by the government's National E-Health Transition Authority (NEHTA). The product incorporates MMR's Australian eHealth patent portfolio combined with VisiInc's Vistime solution and addresses the opportunities created from the launch of Australia's Personal Health Record on July 1 as well as interoperability of numerous eHealth and telehealth platforms being used in countries around the world.
MMR's Personal Health Record products are already interoperable with numerous Electronic Medical Record systems globally and should be capable of meeting changes in future compliance requirements by NEHTA as Australia implements a national eHealth record system. This represents an enormous opportunity for both VisiInc and MMRGlobal to consolidate their technologies and deploy an Australian product base within a fraction of the time of local competitors.
Bob Lorsch, Chairman and Chief Executive Officer of MMRGlobal, said, "As a result of the License Agreement between MMR and VisiInc, our Australian partner is in a position to leverage the MyMedicalRecords Australian patent portfolio to implement a secure NEHTA-compliant service that delivers unified integration of electronic Personal Health Records to work with the takeup of any system, from digitizing plain paper files to transmitting, storing and sharing digital files."
According to Jacques Blandin, Chief Executive Officer and Founder of VisiInc PLC, "This represents an enormous opportunity for both VisiInc and MMR to consolidate and share their technologies and deploy an Australian product base with mature technology that has already gained significant traction internationally. Currently, there are many fragmented product offerings meeting only a small facet of the total solutions globally. Through Vistime and MMR, we have a combined product offering specifically designed to meet the needs of the end user with a powerful yet simple-to-use technology. Vistime is the world's easiest to use multi-file format, real-time 3D viewer for powerful collaboration of medical records, including radiological images, using Visi rapid visual rendering capabilities."
The two Companies will now offer a MyMedicalRecords Personal Health Record in Australia which will include viewing of digital images to NEHTA standards and featuring real-time collaboration between physicians and patients with video and audio conferencing provided through the Visi platform.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.
About VisiInc PLC
VisiInc PLC is a leading software company headquartered in Perth, Australia and registered in the UK, with development and marketing offices located in the USA. Truly a global enterprise, VisiInc's structure delivers efficient access to global equity markets, access to international software and technology markets, and cost-effective Australian-based operations. The company was listed in 2011 on the Frankfurt Stock Exchange (Deutsche Bourse) which is recognised for its ease of trading and as one of the world's most efficient capital markets.
Australia is currently moving toward an eHealth system where secure electronic records and medical file management and sharing will radically improve healthcare and generate up to an estimated $4 billion in software sales over the coming six years. Through its evolutionary Visi™ platform, VisiInc operates Vistime, which is rapidly capturing global market share of major verticals such as Healthcare, Government, Engineering and Architecture, Mining, Oil & Gas, Exploration, Energy, Education, Advertising & Media and Online Video Conferencing. Through its unprecedented rapid visual rendering capabilities, the Vistime system (www.vistime.com) allows all end users to simultaneously view, manipulate, and explore multi-dimensional data visualizations of any file type and of any size, in real-time without any resolution degradation. The system eliminates the lag time barrier that exists with other viewers. As a result, Vistime is the first in the world to enable real-time collaboration of complex, data-rich visual files and 3D media. For more information, visit www.visiinc.com.
Statements in this press release that are not strictly historical in nature, including future performance, expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMRGlobal, Inc.'s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, changes in Australia's eHealth system as it builds and develops; MMRGlobal, Inc. and VisiInc PLC integration and implementations; the risk our products and services are not adopted or viewed favorably by consumers and the healthcare community, both in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry, both in the U.S. and internationally; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing, exploiting and defending our intellectual property rights including those pertaining to our biotechnology assets; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the United States Securities and Exchange Commission. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.